Why we still don’t have personalised medicine, 15 years after sequencing the human genome
- 1 December 2015
The completion of the first draft of the human genome sequence was announced to rapturous applause in June 2000 to an audience of journalists gathered in the White House and Downing Street. Craig Venter, who led one of the two teams of scientists that achieved this remarkable feat, said that having access to this information held “the potential to reduce the number of cancer deaths to zero during our lifetimes”. And President Bill Clinton claimed that “it is now conceivable that our children’s children will know the term cancer as only a constellation of stars”.
Read the full article at The Conversation, written by Bryony Graham, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine
Oxford is a subscribing member of The Conversation. Find out how you can write for The Conversation.